跳到正文
原文
Adam Feuerstein ✡️· @adamfeuerstein · X·· 12 天前AI 评分42
AI 导读

在中国,大量有争议的临床试验减少到涓涓细流 https://www.statnews.com/2026/11/05/china-biotech-restrictions-impact-rare-disease-investigator-initiated-trial/ via @Jasonmmast

正文

In China, a flood of controversial clinical trials slows to a trickle  https://www.statnews.com/2026/11/05/china-biotech-restrictions-impact-rare-disease-investigator-initiated-trial/ via @Jasonmmast

来源:Adam Feuerstein ✡️ · x.com